Enfusion Stock Performance
ENFN Stock | USD 9.51 0.20 2.15% |
On a scale of 0 to 100, Enfusion holds a performance score of 11. The firm shows a Beta (market volatility) of 1.1, which means a somewhat significant risk relative to the market. Enfusion returns are very sensitive to returns on the market. As the market goes up or down, Enfusion is expected to follow. Please check Enfusion's information ratio, downside variance, day typical price, as well as the relationship between the treynor ratio and kurtosis , to make a quick decision on whether Enfusion's price patterns will revert.
Risk-Adjusted Performance
11 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Enfusion are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, Enfusion displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 2.15 | Five Day Return 0.74 | Year To Date Return 1.49 | Ten Year Return (51.99) | All Time Return (51.99) |
1 | New York State Common Retirement Fund Boosts Stock Position in Enfusion, Inc. - MarketBeat | 02/07/2024 |
2 | Disposition of tradable shares by Valeria Gutowski of Enfusion at 8.73 subject to Rule 16b-3 | 02/29/2024 |
3 | Acquisition by Bronwen Bastone of 104603 shares of Enfusion subject to Rule 16b-3 | 03/01/2024 |
4 | Acquisition by Oleg Movchan of 100000 shares of Enfusion subject to Rule 16b-3 | 03/05/2024 |
5 | Enfusion reports mixed Q4 results initiates FY24 outlook | 03/12/2024 |
6 | Q4 2023 Enfusion Inc Earnings Call Transcript | 03/13/2024 |
7 | Wall Street Favorites 3 Under-10 Stocks with Strong Buy Ratings for March 2024 | 03/15/2024 |
8 | Attention Enfusion, Inc. Investors Company Investigated by the Portnoy Law Firm - GlobeNewswire | 03/20/2024 |
9 | Will Enfusion Grow Revenue And Expand Margins In The Future | 04/02/2024 |
10 | The 3 Most Undervalued Under-10 Stocks to Buy in April 2024 | 04/04/2024 |
11 | Enfusion Announces Date of First Quarter 2024 Results | 04/18/2024 |
Begin Period Cash Flow | 62.5 M |
Enfusion |
Enfusion Relative Risk vs. Return Landscape
If you would invest 785.00 in Enfusion on February 2, 2024 and sell it today you would earn a total of 166.00 from holding Enfusion or generate 21.15% return on investment over 90 days. Enfusion is currently generating 0.3273% in daily expected returns and assumes 2.1468% risk (volatility on return distribution) over the 90 days horizon. In different words, 19% of stocks are less volatile than Enfusion, and 94% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
Enfusion Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Enfusion's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Enfusion, and traders can use it to determine the average amount a Enfusion's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1525
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ENFN | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
2.15 actual daily | 19 81% of assets are more volatile |
Expected Return
0.33 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Enfusion is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Enfusion by adding it to a well-diversified portfolio.
Enfusion Fundamentals Growth
Enfusion Stock prices reflect investors' perceptions of the future prospects and financial health of Enfusion, and Enfusion fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Enfusion Stock performance.
Return On Equity | 0.1 | ||||
Return On Asset | 0.0642 | ||||
Profit Margin | 0.03 % | ||||
Operating Margin | 0.05 % | ||||
Current Valuation | 825.9 M | ||||
Shares Outstanding | 90.88 M | ||||
Price To Earning | 0.11 X | ||||
Price To Book | 15.77 X | ||||
Price To Sales | 4.85 X | ||||
Revenue | 174.53 M | ||||
Gross Profit | 103.25 M | ||||
EBITDA | 20.54 M | ||||
Net Income | 6.33 M | ||||
Cash And Equivalents | 56.56 M | ||||
Cash Per Share | 0.84 X | ||||
Total Debt | 15.44 M | ||||
Current Ratio | 9.17 X | ||||
Book Value Per Share | 0.61 X | ||||
Cash Flow From Operations | 24.48 M | ||||
Earnings Per Share | 0.07 X | ||||
Market Capitalization | 846.06 M | ||||
Total Asset | 108.97 M | ||||
Retained Earnings | (172.93 M) | ||||
Working Capital | 49.54 M | ||||
About Enfusion Performance
To evaluate Enfusion Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Enfusion generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Enfusion Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Enfusion market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Enfusion's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 42.58 | 44.71 | |
Return On Tangible Assets | 0.06 | 0.06 | |
Return On Capital Employed | 0.13 | 0.14 | |
Return On Assets | 0.06 | 0.06 | |
Return On Equity | 0.11 | 0.12 |
Things to note about Enfusion performance evaluation
Checking the ongoing alerts about Enfusion for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Enfusion help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Enfusion is unlikely to experience financial distress in the next 2 years | |
Enfusion has a very strong financial position based on the latest SEC filings | |
Over 95.0% of the company shares are held by institutions such as insurance companies | |
Latest headline from businesswire.com: Enfusion Announces Date of First Quarter 2024 Results |
- Analyzing Enfusion's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Enfusion's stock is overvalued or undervalued compared to its peers.
- Examining Enfusion's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Enfusion's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Enfusion's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Enfusion's stock. These opinions can provide insight into Enfusion's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.Note that the Enfusion information on this page should be used as a complementary analysis to other Enfusion's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Enfusion Stock analysis
When running Enfusion's price analysis, check to measure Enfusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enfusion is operating at the current time. Most of Enfusion's value examination focuses on studying past and present price action to predict the probability of Enfusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enfusion's price. Additionally, you may evaluate how the addition of Enfusion to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is Enfusion's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.94) | Earnings Share 0.07 | Revenue Per Share 1.979 | Quarterly Revenue Growth 0.147 | Return On Assets 0.0642 |
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.